Quick Summary

Morinda officinalis (Morinda Root) is a traditional Chinese medicinal herb investigated for various conditions including depressive disorder, Alzheimer’s disease, osteoarthritis, and chronic kidney disease. Clinical evidence is emerging but generally of low to moderate quality. It contains bioactive compounds such as oligosaccharides and iridoids, with potential antioxidant and anti-inflammatory effects.

What is it

Morinda officinalis, commonly known as Morinda Root, is a plant used in traditional Chinese medicine (TCM). Its root extracts have been the focus of research for their bioactive constituents, including oligosaccharides and iridoids, which are thought to contribute to its pharmacological properties.

Traditional Uses

Traditionally, Morinda Root has been employed in TCM to support kidney and bone health, address chronic conditions, and improve vitality. Its use spans treatment approaches for depressive symptoms, neurodegenerative disorders, immune modulation, and inflammatory diseases.

Active Compounds

  • Oligosaccharides
  • Iridoids
  • Other polysaccharides and phytochemicals with potential antioxidant and anti-inflammatory activities

Potential Benefits with Evidence Levels

  • Depressive Disorder: Moderate quality human clinical evidence from a systematic review and meta-analysis of 7 randomized controlled trials (1384 participants) suggests that Morinda officinalis oligosaccharide capsules may have comparable efficacy and safety to conventional antidepressants for mild to moderate depression, though adverse event reporting quality is low. (PMID: 32997072)
  • Alzheimer’s Disease: Preclinical and limited clinical evidence with methodological limitations indicate potential therapeutic effects of Morinda officinalis as part of TCM for Alzheimer’s disease. Effects may be related to modulation of gut microbiota and neuroinflammation, but diagnostic heterogeneity and low study quality restrict conclusions. (PMID: 40948654, PMID: 40657642, PMID: 39081953)
  • Multiple Sclerosis: Limited evidence from randomized controlled trials with suboptimal methodological quality suggests that Chinese herbal medicine therapies including Morinda officinalis, combined with conventional treatments, may improve disability and neurological signs without serious adverse effects. (Systematic review and meta-analysis of 28 RCTs, 1971 participants) (PMID: 41059199)
  • Chronic Kidney Disease (CKD): Preclinical animal studies report that a colon-targeted polysaccharide hydrogel derived from Morinda officinalis (MOPs) may exert renoprotective effects by modulating gut microbiota and reducing intestinal and systemic inflammation in CKD model mice. (PMID: 41692748)
  • Osteoarthritis: Preclinical evidence shows that the Bushen Huoxue formula containing Morinda officinalis ingredients alleviated osteoarthritis inflammation and cartilage damage via IL-17 signaling pathways in animal and cellular models. (PMID: 40421263)

Side Effects

Morinda officinalis oligosaccharide capsules showed no significant difference in adverse events compared to conventional antidepressants in clinical trials, but adverse effect reporting was limited and of low quality. No serious adverse effects have been reported in clinical or preclinical studies. Mild skin irritation has been reported with related plant-derived therapies in other contexts, though not specifically with Morinda officinalis. More rigorous safety assessments are needed.

Drug Interactions

There is no documented clinical evidence of drug interactions involving Morinda officinalis. However, herbal products containing bioactive metabolites may possess potential for pharmacokinetic interactions. Caution is advised when combining Morinda officinalis with pharmaceutical medications until further studies clarify interaction risks.

Who Should Avoid It

Due to limited human safety data, caution is advised in populations lacking adequate safety information. Individuals with known hypersensitivity to Morinda officinalis or related compounds, or those with severe medical conditions, should avoid use unless supervised by a healthcare professional. Pregnant or breastfeeding women should use Morinda officinalis only under medical supervision given insufficient safety evidence.

Evidence Limitations

Most clinical trials included small sample sizes, short durations, and exhibited moderate to low methodological quality. Risk of bias and heterogeneity among studies limit the strength of conclusions drawn. High-quality randomized controlled trials and systematic reviews focused specifically on Morinda officinalis are lacking. Preclinical findings require confirmation through well-designed human studies. Safety data remain limited and are underreported.

References

Last Reviewed

June 2024

Disclaimer: This page is for informational purposes only and does not constitute medical advice. Morinda officinalis and other herbal supplements have not been evaluated by regulatory authorities for safety or efficacy. Consult a qualified healthcare provider before starting any new treatment, especially if you are pregnant, breastfeeding, have underlying health conditions, or are taking other medications.